short-right-arrow logoMobile media-pie 1 7 % share download email linkedin round-download

Privacy Preference Centre

Your Privacy

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. We use two types of cookies on our website: cookies which are necessary for this website to function and analytics cookies. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Cookies used

  • CookieNotice
  • CookieAnalytics

Analytics Cookies

These are Google Analytics cookies which allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site and social media platforms All information these cookies collect is aggregated and therefore anonymous. This cookie is defaulted to ‘Active’, which means we will be able to track, on any anonymous basis, how many visitors we have to our site, and monitor its performance. If you wish to turn them off you can do so by unticking ‘Active’ and clicking ‘Save and Accept Cookies’. For more information on how these cookies work, including a link through to the Google Privacy Policy which sets out further information about data which Google may collect in the course of providing us with Analytics.

Cookies used

  • _ga

Targeting Cookies

We use necessary cookies to make our site work. We also use analytics cookies which collect information about how visitors use our website and help us to improve it; these are defaulted to ‘Active’, if you wish to turn them off you can do so through the Cookie Settings. Please be aware that by blocking some types of cookies it may impact your experience of the site and the services we are able to offer. For more information about any of these cookies and our use of them, or to change your settings at any time, please see Cookie Settings and our Cookies Policy.

Bridgepoint in the News

17 July 2020

Bridgepoint to sell Rovensa in €1 billion transaction

Partners Group, the global private markets investment manager, has on behalf of its clients agreed to acquire a major equity stake in Rovensa ("Rovensa" or "the Company"), a leading provider of specialty crop nutrition, biocontrol and protection products, from Bridgepoint, a major international private equity group. The transaction values the Company at an enterprise value of around EUR 1 billion.

Rovensa's portfolio of agricultural solutions and technologies helps farmers to enhance crop yields and provide food security. Founded in 1926 and headquartered in Portugal, the Company has three divisions: BioNutrition, which provides agricultural crops with nutrients for growth and healthy development; Crop Protection, which eliminates or prevents biological threats in crops; and BioControl, which offers products based on biological inputs, such as plant extracts and micro-organisms. Rovensa specializes in formulating sustainable products which reduce the environmental impact of agriculture, combat its contribution to climate change and support the cultivation of healthy food. Its products are sold in more than 70 countries and generate an annual revenue of approximately EUR 360 million.

Following the investment, Partners Group will work closely with Rovensa's management team, led by Chief Executive Officer Eric van Innis, on several key strategic initiatives, including the accelerated development of the company's leading biological solutions portfolio, the continued internationalization of the company, and select further acquisitions to continue to build its capabilities. In addition, Partners Group plans to continue to support the company's research and development culture, focusing on high-growth market niches.

Eric Van Innis, Chief Executive Officer, Rovensa, says: "We have benefitted greatly from Bridgepoint's ownership since 2017 and our recent growth trajectory reflects this. However, with a growing global population, ambitious environmental targets, and health concerns, the agricultural sector remains essential and we believe its strategic importance ensures there are further exciting growth opportunities ahead. We are convinced that Partners Group, with its global presence and focus on entrepreneurial ownership, is the right partner with which to continue building Rovensa's platform and seize those opportunities. We look forward to working hand-in-hand with Partners Group's team in this next phase of growth and to corresponding to their trust in our project."

Andrew Deakin, Managing Director, Private Equity Directs Europe, Partners Group, states: "Rovensa represents a great opportunity to support a resilient business in a market characterized by steady long-term growth. The Company is ideally positioned to capitalize on the growing trend towards sustainable agricultural products, which will be a core element of the strategy we will continue to pursue. We were attracted to the Company's reputation, talented management team and high-quality product portfolio and see compelling potential for accelerated growth. We are very excited about this meaningful investment in Iberia and are looking forward to supporting Rovensa's continued growth journey."

Hector Perez, partner responsible for Bridgepoint's investment activities in the Iberian region, says: "We are extremely pleased with the progress made by Rovensa since our acquisition in 2017. Today it leads the field globally in BioSolutions and its products have become a prominent component in sustainable agriculture. The business has made a significant leap forward both through continued organic development, fuelled by its product innovation capabilities, and through the execution of six strategic add-on acquisitions. We have enjoyed an extremely productive relationship with a talented management team, led by Eric van Innis and Nuno Loureiro, and are confident of the continued growth of the business in its sector."

Advisers to Bridgepoint were: HSBC, J.P. Morgan, Uría Menéndez, McKinsey and PwC.


Contact us

If you are interested in working for Bridgepoint, please complete the form below.


Investor reports registration

To access investor reports through the web based reporting facility, please fill in the form to register for an account.

The information submitted on this form will be used for the sole purpose of registering you as an account user and will not be shared with third parties.


Request a copy of The Point

Mandatory fields are marked as (required*)